https://doi.org/10.4081/monaldi.2021.1749
Post COVID-19 tuberculosis: An emerging threat of pandemic
Submitted: December 24, 2020
Accepted: January 26, 2021
Published: March 31, 2021
Accepted: January 26, 2021
Abstract Views: 5248
PDF: 1077
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) pandemic has hit the world hard. Millions of people have died due to the infection and several have suffered with what are now known as post COVID-19 squeal. Among these squeals one is immunosuppression which leaves patients prone to severe opportunistic infection. We here report a case of young female who was infected by COVID-19 and later developed cavitary pneumonia which upon investigation turned out to be due to mycobacterium tuberculosis. Through this report we aim to highlight the importance of high index of suspicion for infection like Mycobacterium tuberculosis after COVID-19 infection which developed in a healthy immunocompetent patient.
Harding E. WHO global progress report on tuberculosis elimination. Lancet Respir Med. 2020;8:19.
DOI: https://doi.org/10.1016/S2213-2600(19)30418-7
Bartoletti M, Pascale R, Cricca M, et al. Epidemiology of invasive pulmonary aspergillosis among COVID-19 intubated patients: a prospective study. Clin Infect Dis 2020:ciaa1065.
Choy CY, Wong CS. It's not all about COVID‐19: Pneumocystis pneumonia in the era of a respiratory outbreak. J Int AIDS Soc 2020;23:e25533.
DOI: https://doi.org/10.1002/jia2.25533
Tadolini M, Codecasa LR, García-García JM, et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020;56:2001398.
DOI: https://doi.org/10.1183/13993003.01398-2020
Gupta N, Ish P, Gupta A, et al. A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis. Eur Respir J 2020;56:2003408.
DOI: https://doi.org/10.1183/13993003.03408-2020
Rakesh PS, et al. Mortality among individuals with TB-COVID-19 coinfection: initial observations from Kerala, India. Int J Tuberc Lung Dis 2021; in press
Motta I, Centis R, D’Ambrosio L, et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 2020;26:233-40.
DOI: https://doi.org/10.1016/j.pulmoe.2020.05.002
Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med 2013;2013:828939.
DOI: https://doi.org/10.1155/2013/828939
Zumla A, Marais BJ, McHugh TD, et al. COVID-19 and tuberculosis—threats and opportunities. Int J Tubercul Lung Dis 2020;24:757-60.
DOI: https://doi.org/10.5588/ijtld.20.0387
Alagna R, Besozzi G, Codecasa LR, et al. Celebrating world tuberculosis day at the time of COVID-19. Eur Respir J 2020;55:2000650.
DOI: https://doi.org/10.1183/13993003.00650-2020
Dara M, Sotgiu G, Reichler MR, et al. New diseases and old threats: lessons from tuberculosis for the COVID-19 response. Int J Tuberc Lung Dis 2020;24:544-5.
DOI: https://doi.org/10.5588/ijtld.20.0151
Migliori GB, Thong PM, Akkerman O, et al. Worldwide effects of coronavirus disease pandemic on tuberculosis services, January–April 2020. Emerg Infect Dis 2020;26:2709.
DOI: https://doi.org/10.3201/eid2611.203163
Supporting Agencies
noneHow to Cite
Zahid, Aqusa, Nousheen Iqbal, Sarosh Moeen, and Muhammad Irfan. 2021. “Post COVID-19 Tuberculosis: An Emerging Threat of Pandemic”. Monaldi Archives for Chest Disease 91 (3). https://doi.org/10.4081/monaldi.2021.1749.
Copyright (c) 2021 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Amitesh Gupta, Eshutosh Chandra, Shipra Anand, Naresh Kumar, Richa Arora, Divyanshi Rana, Parul Mrigpuri, Latent tuberculosis diagnostics: current scenario and review , Monaldi Archives for Chest Disease: Early Access
- Moncef Maiouak, Vanessa Garcia-Larsen, Soumaya Benmaamar, Ibtissam El Harch, Mohamed El Biaz, Chakib Nejjari, Mohammed Chakib Benjelloun, Karima El Rhazi, Factors influencing health-related quality of life in patients with chronic obstructive pulmonary disease: insights from the Burden of Obstructive Lung Disease Study in Fez, Morocco , Monaldi Archives for Chest Disease: Early Access
- Matilde Boccia, Luigi Aronne, Benito Celia, Grazia Mazzeo, Maria Ceparano, Vito D'Agnano, Roberto Parrella, Tullio Valente, Andrea Bianco, Fabio Perrotta, COVID-19 and coagulative axis: review of emerging aspects in a novel disease , Monaldi Archives for Chest Disease: Vol. 90 No. 2 (2020)
- Hussein Soleimantabar, Sofia Sabouri, Leila Khedmat, Samira Salajeghe, Behzad Memari, Bahareh Heshmat Ghahderijani, Assessment of CT angiographic findings in comparison with echocardiography findings of chest among patients with aortic arch anomalies , Monaldi Archives for Chest Disease: Vol. 89 No. 3 (2019)
- Vasiliki Epameinondas Georgakopoulou, Nikolaos Garmpis, Dimitrios Mermigkis, Christos Damaskos, Serafeim Chlapoutakis, Konstantinos Mantzouranis, Aikaterini Gkoufa, Chrysovalantis Papageorgiou, Anna Garmpi, Sotiria Makrodimitri, Evangelos Diamantis, Pagona Sklapani, Nikolaos Trakas, Xanthi Tsiafaki, Pulmonary adverse events due to immune checkpoint inhibitors: A literature review , Monaldi Archives for Chest Disease: Vol. 92 No. 2 (2022)
- Hiroaki Satoh, Yuika Sasatani, Pulmonary co-infection with Actinomyces odontolyticus and Mycobacterium kansashii , Monaldi Archives for Chest Disease: Vol. 92 No. 3 (2022)
- Danish Abdul Aziz, Muhammad Aqib Sajjad, Ameema Asad, Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years , Monaldi Archives for Chest Disease: Vol. 94 No. 3 (2024)
- Pietro Impellizzeri, Santi Nolasco, Raffaele Campisi, Antonino Cipolla, Alba Borgese, Stefano Alia, Nunzio Crimi, Claudia Crimi, Acute and long-term management of severe bronchiectasis with high flow nasal therapy: a case report , Monaldi Archives for Chest Disease: Vol. 93 No. 2 (2023)
- Joana Almeida Borges, Antonio M. Esquinas, Biphasic cuirass ventilation in the escalation of non-invasive ventilation in COVID-19: Case report and review , Monaldi Archives for Chest Disease: Vol. 93 No. 4 (2023)
- Diletta Innocenti, Chiara Castellani, Eleonora Masi, Valeria Galici, Letizia Macconi, Giovanni Taccetti, Can percussive intrapulmonary ventilation improve the efficacy of physiotherapy in children with cystic fibrosis? , Monaldi Archives for Chest Disease: Vol. 94 No. 1 (2024)
<< < 26 27 28 29 30 31 32 33 34 35 > >>
You may also start an advanced similarity search for this article.
